Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification

被引:38
作者
Bosman, Laurens P. [1 ,2 ]
te Riele, Anneline S. J. M. [1 ,2 ]
机构
[1] UMC Utrecht, Cardiol, Utrecht, Netherlands
[2] ICIN Netherlands Heart Inst, Utrecht, Netherlands
关键词
arrhythmogenic right ventricular dysplasia; risk factors; diagnostic imaging; defibrillators; implantable; genetic diseases; inborn; TASK-FORCE CRITERIA; MAGNETIC-RESONANCE; DYSPLASIA; EXERCISE; MUTATION; DISEASE; WAVES;
D O I
10.1136/heartjnl-2021-319113
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiomyopathy characterised by fibrofatty replacement of predominantly the right ventricle and high risk of ventricular arrhythmias and sudden cardiac death (SCD). Early diagnosis and accurate risk assessment are challenging yet essential for SCD prevention. This manuscript summarises the current state of the art on ARVC diagnosis and risk stratification. Improving the 2010 diagnostic criteria is an ongoing discussion. Several studies suggest that early diagnosis may be facilitated by including deformation imaging ('strain') for objective assessment of wall motion abnormalities, which was shown to have high sensitivity for preclinical disease. Adding fibrofatty replacement detected by late gadolinium enhancement or T1 mapping in cardiac MRI as criterion for diagnosis is increasingly suggested but requires more supporting evidence from consecutive patient cohorts. In addition to the traditional right-dominant ARVC, standard criteria for arrhythmogenic cardiomyopathy (ACM) and arrhythmogenic left ventricular cardiomyopathy (ALVC) are on the horizon. After diagnosis confirmation, the primary management goal is SCD prevention, for which an implantable cardioverter-defibrillator is the only proven therapy. Prior studies determined that younger age, male sex, previous (non-) sustained ventricular tachycardia, syncope, extent of T-wave inversion, frequent premature ectopic beats and lower biventricular ejection fraction are risk factors for subsequent events. Previous implantable cardioverter-defibrillator indication guidelines were however limited to three expert-opinion flow charts stratifying patients in risk groups. Now, two multivariable risk prediction models (arvcrisk.com) combine the abovementioned risk factors to estimate individual risks. Of note, both the flow charts and prediction models require clinical validation studies to determine which should be recommended.
引用
收藏
页码:90 / 97
页数:8
相关论文
共 50 条
[1]  
Al-Khatib SM, 2018, CIRCULATION, V138, pE272, DOI [10.1161/CIR.0000000000000549, 10.1161/CIR.0000000000000548]
[2]   Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy [J].
Aquaro, Giovanni Donato ;
De Luca, Antonio ;
Cappelletto, Chiara ;
Raimondi, Francesca ;
Bianco, Francesco ;
Botto, Nicoletta ;
Barison, Andrea ;
Romani, Simona ;
Lesizza, Pierluigi ;
Fabris, Enrico ;
Todiere, Giancarlo ;
Grigoratos, Crysanthos ;
Pingitore, Alessandro ;
Stolfo, Davide ;
Dal Ferro, Matteo ;
Merlo, Marco ;
Di Bella, Gianluca ;
Sinagra, Gianfranco .
ESC HEART FAILURE, 2020, 7 (06) :4080-4088
[3]  
Aquaro GD, 2020, J AM COLL CARDIOL, V75, P2753, DOI 10.1016/j.jacc.2020.04.023
[4]   Usefulness of Combined Functional Assessment by Cardiac Magnetic Resonance and Tissue Characterization Versus Task Force Criteria for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy [J].
Aquaro, Giovanni Donato ;
Barison, Andrea ;
Todiere, Giancarlo ;
Grigoratos, Chrysanthos ;
Ali, Lamia Ait ;
Di Bella, Gianluca ;
Emdin, Michele ;
Festa, Pierluigi .
AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (11) :1730-1736
[5]  
Assis Fabrizio R, 2020, Card Electrophysiol Clin, V12, P329, DOI 10.1016/j.ccep.2020.05.005
[6]   Molecular mechanisms of arrhythmogenic cardiomyopathy [J].
Austin, Karyn M. ;
Trembley, Michael A. ;
Chandler, Stephanie E. ;
Sanders, Stephen P. ;
Saffitz, Jeffrey E. ;
Abrams, Dominic J. ;
Pu, William T. .
NATURE REVIEWS CARDIOLOGY, 2019, 16 (09) :519-537
[7]   Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria [J].
Basso, Cristina ;
Ronco, Federico ;
Marcus, Frank ;
Abudureheman, Aierken ;
Rizzo, Stefania ;
Frigo, Anna Chiara ;
Bauce, Barbara ;
Maddalena, Francesco ;
Nava, Andrea ;
Corrado, Domenico ;
Grigoletto, Francesco ;
Thiene, Gaetano .
EUROPEAN HEART JOURNAL, 2008, 29 (22) :2760-2771
[8]   Arrhythmogenic Right Ventricular Cardiomyopathy: What's in a Name? From a Congenital Defect (Dysplasia) to a Genetically Determined Cardiomyopathy (Dystrophy) [J].
Basso, Cristina ;
Corrado, Domenico ;
Thiene, Gaetano .
AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (02) :275-277
[9]   Diagnosing arrhythmogenic right ventricular cardiomyopathy by 2010 Task Force Criteria: clinical performance and simplified practical implementation [J].
Bosman, Laurens P. ;
Cadrin-Tourigny, Julia ;
Bourfiss, Mimount ;
Ghasabeh, Mounes Aliyari ;
Sharma, Apurva ;
Tichnell, Crystal ;
Roudijk, Rob W. ;
Murray, Brittney ;
Tandri, Harikrishna ;
Khairy, Paul ;
Kamel, Ihab R. ;
Zimmerman, Stefan L. ;
Reitsma, Johannes B. ;
Asselbergs, Folkert W. ;
van Tintelen, J. Peter ;
van der Heijden, Jeroen F. ;
Hauer, Richard N. W. ;
Calkins, Hugh ;
James, Cynthia A. ;
te Riele, Anneline S. J. M. .
EUROPACE, 2020, 22 (05) :787-796
[10]   Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis [J].
Bosman, Laurens P. ;
Sammani, Arjan ;
James, Cynthia A. ;
Cadrin-Tourigny, Julia ;
Calkins, Hugh ;
van Tintelen, J. Peter ;
Hauer, Richard N. W. ;
Asselbergs, Folkert W. ;
te Riele, Anneline S. J. M. .
HEART RHYTHM, 2018, 15 (07) :1097-1107